Ajanta Pharma introduces memantine hydrochloride tablets in US market

Ajanta Pharma Limited, announced the launch of memantine hydrochloride tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA Inc. Memantine hydrochloride is an anti-dementia drug and is a bioequivalent generic version of Namenda.Ajanta-Pharma

The company has launched it in 2 strengths 5mg and 10mg tablets to address different levels of treatment.

Memantine hydrochloride tablets is part of an ever-growing portfolio of products that Ajanta has developed for the US market. To date, the United States Food & Drug Administration (FDA) has granted Ajanta Pharma 10 final approvals and 2 tentative approvals for its Abbreviated New Drug Application (ANDA). Additional 14 ANDAs are pending approval from the FDA.

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn0Share on StumbleUpon0Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top